Global Patent Index - EP 0008229 A1

EP 0008229 A1 19800220 - Spiro-furanohydantoin derivatives, process for their preparation and pharmaceutical compositions containing them.

Title (en)

Spiro-furanohydantoin derivatives, process for their preparation and pharmaceutical compositions containing them.

Title (de)

Spiro-furanohydantoinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.

Title (fr)

Dérivés de la spiro-furanohydantoine, procédé pour leur préparation et compositions pharmaceutiques les contenant.

Publication

EP 0008229 A1 19800220 (EN)

Application

EP 79301609 A 19790808

Priority

US 93299078 A 19780811

Abstract (en)

Spiro-furanohydantoin derivatives of the formula: <CHEM> and pharmaceutically acceptable metal salts wherein R is hydrogen, methyl, fluoro, chloro or bromo and pharmaceutical compositions thereof are aldose reductase inhibitors useful as therapeutic agents for preventing or alleviating chronic diabetic complications such as diabetic cataracts and neuropathy.

IPC 1-7

C07D 491/107; A61K 31/415

IPC 8 full level

A61K 31/415 (2006.01); A61P 13/02 (2006.01); A61P 15/00 (2006.01); A61P 25/00 (2006.01); A61P 25/02 (2006.01); A61P 27/02 (2006.01); A61P 27/12 (2006.01); C07D 491/10 (2006.01); C07D 491/107 (2006.01)

CPC (source: EP US)

A61P 13/02 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/02 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 27/12 (2017.12 - EP); C07D 491/10 (2013.01 - EP US)

Citation (search report)

Designated contracting state (EPC)

BE CH DE FR GB IT LU NL SE

DOCDB simple family (publication)

US 4147797 A 19790403; DE 2964209 D1 19830113; DK 335279 A 19800212; EP 0008229 A1 19800220; EP 0008229 B1 19821208; IE 48585 B1 19850306; IE 791540 L 19800211; JP S5527193 A 19800227; JP S5817760 B2 19830409

DOCDB simple family (application)

US 93299078 A 19780811; DE 2964209 T 19790808; DK 335279 A 19790810; EP 79301609 A 19790808; IE 154079 A 19790810; JP 10212379 A 19790810